Basics |
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
|
IPO Date: |
June 9, 2017 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$18.21M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.07 | 4.27%
|
Avg Daily Range (30 D): |
$0.12 | 9.44%
|
Avg Daily Range (90 D): |
$0.08 | 6.66%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.61M |
Avg Daily Volume (30 D): |
4.11M |
Avg Daily Volume (90 D): |
1.56M |
Trade Size |
Avg Trade Size (Sh.): |
397 |
Avg Trade Size (Sh.) (30 D): |
292 |
Avg Trade Size (Sh.) (90 D): |
280 |
Institutional Trades |
Total Inst.Trades: |
45 |
Avg Inst. Trade: |
$2.78M |
Avg Inst. Trade (30 D): |
$6.8M |
Avg Inst. Trade (90 D): |
$6.8M |
Avg Inst. Trade Volume: |
.06M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$6.35M |
Avg Closing Trade (30 D): |
$6.8M |
Avg Closing Trade (90 D): |
$6.8M |
Avg Closing Volume: |
149.91K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-5.76
|
$-1.27
|
$-1.31
|
Diluted EPS
|
$-5.76
|
$-1.27
|
$-1.31
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -43.44M
|
$ -11.51M
|
$ -10.28M
|
Operating Income / Loss
|
$ -42.98M
|
$ -11.26M
|
$ -10.04M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -9.31M
|
$
|
$
|
PE Ratio
|
|
|
|
Splits |
Nov 26, 2024:
1:25
|
Jun 09, 2017:
1:15
|
Sep 12, 2014:
5:8
|
|
|
|